Cargando…
The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons
The lack of early diagnostic biomarkers for schizophrenia greatly limits treatment options that deliver therapeutic agents to affected cells at a timely manner. While previous schizophrenia biomarker research has identified various biological signals that are correlated with certain diseases, their...
Autores principales: | Lee, Davin, Seo, Jinsoo, Jeong, Hae chan, Lee, Hyosang, Lee, Sung Bae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633873/ https://www.ncbi.nlm.nih.gov/pubmed/34867186 http://dx.doi.org/10.3389/fnmol.2021.756613 |
Ejemplares similares
-
Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
por: Fernández‐Santiago, Rubén, et al.
Publicado: (2015) -
Human iPSC Neurons Display Activity-Dependent Neurotransmitter Secretion: Aberrant Catecholamine Levels in Schizophrenia Neurons
por: Hook, Vivian, et al.
Publicado: (2014) -
Transcriptomic and epigenomic dynamics associated with development of human iPSC-derived GABAergic interneurons
por: Inglis, George Andrew S, et al.
Publicado: (2020) -
Naked Mole Rat Cells Have a Stable Epigenome that Resists iPSC Reprogramming
por: Tan, Li, et al.
Publicado: (2017) -
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
por: Collo, Ginetta, et al.
Publicado: (2020)